Create
Query
event_store.db
—
signals
actions
approvals
artifacts
commitments
constraints
conversation_compaction
conversation_state
conversation_turns
dead_letters
decisions
deliveries
effects
email_messages
email_reply_drafts
email_threads
entities
entity_aliases
entity_tags
episode_context_index
episodes
event_subjects
events
events_archive
fact_sources
facts
inbox_items
inbox_links
jobs
leader_leases
links
memory_candidates
memory_embeddings
memory_items
memory_items_fts
(v)
memory_items_fts_config
memory_items_fts_data
memory_items_fts_idx
opportunity_memory
pending_interactions
proposal_sources
proposals
reminders
schedules
schema_migrations
signal_candidates
signal_fps
signals
sms_conversations
sms_messages
sms_reply_drafts
source_cursors
sources
sqlite_sequence
sqlite_stat1
stream_cursors
threads
watchers
Toggle helper tables
memory_items_fts_content
memory_items_fts_docsize
memory_items_fts_segdir
memory_items_fts_segments
memory_items_fts_stat
Structure
Content
Query
Insert
Drop
Import
Export
Update row sig_4b824ea600f4 in signals
id
sig_4b824ea600f4
Primary key.
TEXT
event_id
13152
TEXT NOT NULL
watcher_id
NULL
TEXT
signal_type
discovery_ipo_delta
TEXT NOT NULL
value
{"aggregator_url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5oREVnNnhiZm1vQmpzbVdNLXlIQ01hWDFoLXdqM05obVhOclJJTWoxOTlkY3dMTk9HdDJBV1RhaFpYZG9Ya3I2Qm9FMktwUlhsWldv?oc=5","as_of":"2026-04-09T22:59:43.472613+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5oREVnNnhiZm1vQmpzbVdNLXlIQ01hWDFoLXdqM05obVhOclJJTWoxOTlkY3dMTk9HdDJBV1RhaFpYZG9Ya3I2Qm9FMktwUlhsWldv?oc=5","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_1eef5a68681ec41b","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-10T02:47:55.644133+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5oREVnNnhiZm1vQmpzbVdNLXlIQ01hWDFoLXdqM05obVhOclJJTWoxOTlkY3dMTk9HdDJBV1RhaFpYZG9Ya3I2Qm9FMktwUlhsWldv?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"gstatic.com","publisher_resolution":"canonical_aggregator_unresolved","requested_url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5oREVnNnhiZm1vQmpzbVdNLXlIQ01hWDFoLXdqM05obVhOclJJTWoxOTlkY3dMTk9HdDJBV1RhaFpYZG9Ya3I2Qm9FMktwUlhsWldv?oc=5","source_event_id":"evt_584c61f84701","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"be511b9b02d4bccf","kind":"ipo_calendar","published_at":"2026-04-09T21:53:59+00:00","publisher_domain":"gstatic.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.62,"dates_mentioned":[],"entities":[{"asset_class":"equity","name":"Avalyn","relevance":"high","symbol":"","type":"company"},{"asset_class":"media","name":"FirstWord Pharma","relevance":"high","symbol":"","type":"publisher"}],"event_type":"listing","information_gaps":["The provided article text is not actually present (only CSS/HTML styling is included), so no verifiable details about the IPO (e.g., timing, exchange, offering size, underwriters, ticker) can be extracted.","The phrase \u201cinhaled lung disease hopefuls\u201d is not defined in the provided text; no other company names are available.","No confirmation is provided on whether Avalyn itself is the IPO issuer or whether it is associated with other \u201chopefuls.\u201d"],"key_facts":["Headline states that Avalyn and inhaled lung disease hopefuls have joined the IPO queue.","Source attributed to FirstWord Pharma."],"numeric_claims":[],"primary_claim":"Avalyn and its inhaled lung disease-focused hopefuls have joined the IPO queue, according to FirstWord Pharma.","relevance_score":0.45,"sentiment":"neutral","source_quality":"high","summary":"The signal indicates that Avalyn and companies developing inhaled lung disease therapies have entered the IPO pipeline, as reported by FirstWord Pharma. No additional IPO terms or company details are present in the provided text.","topics":["IPO queue","Avalyn","inhaled lung disease therapies","FirstWord Pharma"]},"source":"FirstWord Pharma","source_domain":"gstatic.com","summary":"Avalyn and its inhaled lung disease hopefuls join the IPO queue FirstWord Pharma","tickers":[],"title":"Avalyn and its inhaled lung disease hopefuls join the IPO queue - FirstWord Pharma","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp"}
TEXT NOT NULL
threshold
NULL
TEXT
direction
NULL
TEXT
severity
NULL
TEXT
window
NULL
TEXT
source
discovery_ingestor
TEXT NOT NULL
reason_trace
{"_evidence_event_ids":["evt_584c61f84701"]}
TEXT
dedupe_key
signal_enriched:discovery_ipo_delta:1820aa2964506413
TEXT NOT NULL
throttle_s
INTEGER (default 0
created_at
2026-04-09T22:59:43.472613+00:00
TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')
Update
Cancel